Clinical Trials Directory

Trials / Conditions / Kidney Medullary Carcinoma

Kidney Medullary Carcinoma

7 registered clinical trials studyying Kidney Medullary Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingTiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
NCT05286801
National Cancer Institute (NCI)Phase 1 / Phase 2
Active Not RecruitingTesting the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) f
NCT04071223
National Cancer Institute (NCI)Phase 2
RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted
NCT03866382
National Cancer Institute (NCI)Phase 2
TerminatedPhase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
NCT03274258
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourin
NCT02496208
National Cancer Institute (NCI)Phase 1
CompletedPazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
NCT01767636
Mayo ClinicPhase 2
Active Not RecruitingStudy of Kidney Tumors in Younger Patients
NCT00898365
Children's Oncology Group—